Snapshot · The Mel Robbins Podcast
Contrary to the older view that dreaming is confined to REM sleep, current evidence shows dreams can occur during sleep entry, mid-sleep, and sleep exit across all phases.
Where this was said
At 18:46 · chapter starts 17:50
Using blocks to visualize the architecture of sleep, Dr. Jandial traces the progression from sleep entry (N1) through progressively deeper phases (N2, N3) and into REM — Rapid Eye Movement sleep, when eyes move rapidly behind closed lids and the brain enters its most dream-fertile mode. The old scientific consensus held that meaningful dreaming was confined to REM. The newer picture, built from sleep labs where people are woken at random intervals and asked to report, is more expansive: dreams can occur at any phase of sleep, including right at the edges of falling asleep and waking up. This is both scientifically important and practically useful — it means the transitional moments at sleep entry and exit are fertile ground for dream capture and dream priming, not just the deep-night REM phases.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.